author-photo

Hollis Dsouza

Tata Memorial Hospital

15

Papers

28

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastoma

2021 Ecancermedicalscience
Show All
- Source
- Cite
- Save
Citations (0)
Optimal dose of bevacizumab in recurrent glioma: A retrospective study

2021
Show All
- Source
- Cite
- Save
Citations (0)
Safety and efficacy of bevacizumab biosimilar in glioma.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Aprepitant in weekly cisplatin with radiation in head and neck cancer: Is it required?

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
345P Thromboembolic events in brain tumour patients on bevacizumab

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Long-term outcomes of locally advanced and borderline resectable esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation treated with neoadjuvant chemotherapy

2020
Show All
- Source
- Cite
- Save
Citations (0)
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.

2020 The Lancet Global Health
Show All
- Source
- Cite
- Save
Citations (17)
Thromboembolic events in brain tumour patients on bevacizumab.

2020 Acta Oncologica
Show All
- Source
- Cite
- Save
Citations (0)
Chemoradiation in Unresectable Oral Cavity Cancer: A Myth or Reality!

2020 South Asian Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Indication of adjuvant chemoradiation post neoadjuvant chemotherapy in very locally advanced borderline resectable head and neck cancer.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)